BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

881 related articles for article (PubMed ID: 23728147)

  • 1. Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?
    Briand N; Warszawski J; Mandelbrot L; Dollfus C; Pannier E; Cravello L; Nguyen R; Matheron I; Winer N; Tubiana R; Rouzioux C; Faye A; Blanche S;
    Clin Infect Dis; 2013 Sep; 57(6):903-14. PubMed ID: 23728147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.
    Warszawski J; Tubiana R; Le Chenadec J; Blanche S; Teglas JP; Dollfus C; Faye A; Burgard M; Rouzioux C; Mandelbrot L;
    AIDS; 2008 Jan; 22(2):289-99. PubMed ID: 18097232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort.
    Peters V; Liu KL; Dominguez K; Frederick T; Melville S; Hsu HW; Ortiz I; Rakusan T; Gill B; Thomas P
    Pediatrics; 2003 May; 111(5 Pt 2):1186-91. PubMed ID: 12728136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is peripartum zidovudine absolutely necessary for patients with a viral load less than 1,000 copies/ml?
    Wong VV
    J Obstet Gynaecol; 2011 Nov; 31(8):740-2. PubMed ID: 22085066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapartum zidovudine infusion alone failed to reduce both maternal HIV-1 viral load and HIV-1 infection in infant.
    Limpongsanurak S; Thaithumyanon P; Thisyakorn U; Ruxrungtham K; Chaithongwongwatthana S; Kongsin P; Tarounotai U; Chantheptaewan N; Triratwerapong T; Ubolyam S; Phanuphak P
    J Med Assoc Thai; 2001 May; 84(5):611-6. PubMed ID: 11560207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cesarean section for HIV-infected women in the combination antiretroviral therapies era, 2000-2010.
    Briand N; Jasseron C; Sibiude J; Azria E; Pollet J; Hammou Y; Warszawski J; Mandelbrot L
    Am J Obstet Gynecol; 2013 Oct; 209(4):335.e1-335.e12. PubMed ID: 23791563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
    Taha TE; Kumwenda NI; Hoover DR; Fiscus SA; Kafulafula G; Nkhoma C; Nour S; Chen S; Liomba G; Miotti PG; Broadhead RL
    JAMA; 2004 Jul; 292(2):202-9. PubMed ID: 15249569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
    Moodley D; Moodley J; Coovadia H; Gray G; McIntyre J; Hofmyer J; Nikodem C; Hall D; Gigliotti M; Robinson P; Boshoff L; Sullivan JL;
    J Infect Dis; 2003 Mar; 187(5):725-35. PubMed ID: 12599045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematological effects of zidovudine prophylaxis in newborn infants with and without prenatal exposure to zidovudine.
    Baroncelli S; Pinnetti C; Genovese O; Tamburrini E; Floridia M
    J Med Virol; 2011 Mar; 83(3):551-6. PubMed ID: 21264878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.
    Dabis F; Bequet L; Ekouevi DK; Viho I; Rouet F; Horo A; Sakarovitch C; Becquet R; Fassinou P; Dequae-Merchadou L; Welffens-Ekra C; Rouzioux C; Leroy V;
    AIDS; 2005 Feb; 19(3):309-18. PubMed ID: 15718842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.
    Mofenson LM; Lambert JS; Stiehm ER; Bethel J; Meyer WA; Whitehouse J; Moye J; Reichelderfer P; Harris DR; Fowler MG; Mathieson BJ; Nemo GJ
    N Engl J Med; 1999 Aug; 341(6):385-93. PubMed ID: 10432323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1).
    Tubiana R; Le Chenadec J; Rouzioux C; Mandelbrot L; Hamrene K; Dollfus C; Faye A; Delaugerre C; Blanche S; Warszawski J
    Clin Infect Dis; 2010 Feb; 50(4):585-96. PubMed ID: 20070234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission.
    Short CE; Douglas M; Smith JH; Taylor GP
    HIV Med; 2014 Apr; 15(4):233-8. PubMed ID: 24025074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in Thailand.
    Jourdain G; Mary JY; Coeur SL; Ngo-Giang-Huong N; Yuthavisuthi P; Limtrakul A; Traisathit P; McIntosh K; Lallemant M;
    J Infect Dis; 2007 Dec; 196(11):1629-36. PubMed ID: 18008246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of human immunodeficiency virus mother-to-child transmission in Israel.
    Agmon-Levin N; Elbirt D; Asher I; Torten D; Cohen Y; Gradestein S; Werner B; Turner D; Chowers M; Gottesman G; Maayan S; Risenberg K; Levi I; Sthoeger Z
    Int J STD AIDS; 2009 Jul; 20(7):473-6. PubMed ID: 19541889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in perinatal transmission and mortality from human immunodeficiency virus after intervention with zidovudine in Barbados.
    St John AM; Kumar A; Cave C
    Pediatr Infect Dis J; 2003 May; 22(5):422-6. PubMed ID: 12792382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.